[A new combined peroral drug for tuberculosis therapy].
D000447:Aldehydes / Q000627:therapeutic use*; D004338:Drug Combinations; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D000447:Aldehydes; D004338:Drug Combinations; D009539:Nicotinic Acids; D013882:Thiosemicarbazones; D009525:Niacin
ALDEHYDES/therapeutic use; NICOTINIC ACID ISOMERS/therapeutic use; NICOTINIC ACID/derivatives; THIOSEMICARBAZONES/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
Uber ein neues kombiniertes, perorales Tuberkuloseheilmittel.